Related references
Note: Only part of the references are listed.Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms
Stefan Walbaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models
Vasilios Liapis et al.
MOLECULAR IMAGING AND BIOLOGY (2021)
Phagocytosis of Necrotic Debris at Sites of Injury and Inflammation
Johannes Westman et al.
FRONTIERS IN IMMUNOLOGY (2020)
Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
Hilma J. van der Horst et al.
CANCERS (2020)
Improved non-invasive positron emission tomographic imaging of chemotherapy-induced tumor cell death using Zirconium-89-labeled APOMAB®
Vasilios Liapis et al.
EJNMMI RADIOPHARMACY AND CHEMISTRY (2020)
Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody
Alexander H. Staudacher et al.
JOURNAL OF CONTROLLED RELEASE (2020)
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor model
Heng Sheng Sow et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Mouse Strains Influence Clearance and Efficacy of Antibody and Antibody-Drug Conjugate Via Fc-FcγR Interaction
Fu Li et al.
MOLECULAR CANCER THERAPEUTICS (2019)
APOMAB Antibody-Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo
Alexander H. Staudacher et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Affinity of human IgG subclasses to mouse Fc gamma receptors
Gillian Dekkers et al.
MABS (2017)
Tumor-Associated Macrophages Can Contribute to Antitumor Activity through FcγR-Mediated Processing of Antibody-Drug Conjugates
Fu Li et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?
Alexander H. Staudacher et al.
BRITISH JOURNAL OF CANCER (2017)
A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies
Stacey E. Rudd et al.
CHEMICAL COMMUNICATIONS (2016)
Immunoglobulin isotype knowledge and application to Fc engineering
Randall J. Brerski et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis
Rony Dahan et al.
CANCER CELL (2015)
Monte Carlo simulations of dose distributions with necrotic tumor targeted radioimmunotherapy
Scott N. Penfold et al.
APPLIED RADIATION AND ISOTOPES (2014)
FcRγ-Chain ITAM Signaling Is Critically Required for Cross-Presentation of Soluble Antibody-Antigen Complexes by Dendritic Cells
Peter Boross et al.
JOURNAL OF IMMUNOLOGY (2014)
Postchemotherapy and Tumor-Selective Targeting with the La-Specific DAB4 Monoclonal Antibody Relates to Apoptotic Cell Clearance
Fares Al-Ejeh et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Targeted α-therapy using 227Th-APOMAB and cross-fire antitumour effects: preliminary in-vivo evaluation
Alexander H. Staudacher et al.
NUCLEAR MEDICINE COMMUNICATIONS (2014)
The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB®
Alexander H. Staudacher et al.
EJNMMI RESEARCH (2014)
Clearing the Dead: Apoptotic Cell Sensing, Recognition, Engulfment, and Digestion
Amelia Hochreiter-Hufford et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Both activating and inhibitory Fc gamma receptors mediate rituximab-induced trogocytosis of CD20 in mice
Peter Boross et al.
IMMUNOLOGY LETTERS (2012)
In vivo Cytotoxicity of Type I CD20 Antibodies Critically Depends on Fc Receptor ITAM Signaling
Simone de Haij et al.
CANCER RESEARCH (2010)
Immunotargeting of Functional Nanoparticles for MRI detection of Apoptotic Tumor Cells
Benjamin Thierry et al.
ADVANCED MATERIALS (2009)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
Macrophages and Fc-receptor interactions contribute to the antitumour activities of the anti-CD40 antibody SGN-40
E. Oflazoglu et al.
BRITISH JOURNAL OF CANCER (2009)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
APOMAB®, a La-Specific Monoclonal Antibody, Detects the Apoptotic Tumor Response to Life-Prolonging and DNA-Damaging Chemotherapy
Fares Al-Ejeh et al.
PLOS ONE (2009)
Chemotherapy Synergizes with Radioimmunotherapy Targeting La Autoantigen in Tumors
Fares Al-Ejeh et al.
PLOS ONE (2009)
Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30
Ezogelin Oflazoglu et al.
BLOOD (2007)
La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity
Mingguo Huang et al.
LIFE SCIENCES (2007)
The la autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugs
Fares Al-Ejeh et al.
CLINICAL CANCER RESEARCH (2007)
In vivo targeting of dead tumor cells in a murine tumor model using a monoclonal antibody specific for the la autoantigen
Fares Al-Ejeh et al.
CLINICAL CANCER RESEARCH (2007)
Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1
M Hezareh et al.
JOURNAL OF VIROLOGY (2001)
La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis
K Ayukawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages
ME Miranda-Carús et al.
JOURNAL OF IMMUNOLOGY (2000)
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
